Latest Regulatory News

Uscom Limited’s shares have been suspended from trading on the ASX due to concerns over its financial health, following a critical auditor’s disclaimer. The suspension will remain until the company meets regulatory requirements.

Bayan Mining And Minerals Limited’s BMMO securities have been suspended from ASX trading due to non-compliance with listing rules, raising questions about the company’s next steps.

Blue Energy Limited invites eligible shareholders to participate in a discounted Share Purchase Plan, offering shares at $0.005 each, matching a recent institutional placement price. The plan aims to raise up to $250,000, providing retail investors a rare chance to buy shares at a significant discount.

Rimfire Pacific Mining is set to begin a fully funded 24-hole drilling campaign at its Rabbit Trap Scandium Project in central New South Wales, targeting promising laterite-hosted scandium mineralisation.

Reef Casino Trust (ASX, RCT) has received a recommended off-market takeover offer from Iris Cairns Property Pty Ltd at $3.87 per unit, representing a significant premium over recent trading prices. The independent expert affirms the offer as fair and reasonable, with major unitholders supporting the bid subject to regulatory approvals.

Redcastle Resources and BML advance their strategic gold joint venture with key studies completed and mining proposal submission expected by late 2025, targeting initial production in early 2026.

Metal Bank Limited has signed a binding agreement to acquire key gold assets from Hastings Technology Metals, marking a significant expansion of its Western Australian portfolio. Drilling has already commenced at the Whiteheads Project’s Seven Leaders prospect, signaling early progress.

Hastings Technology Metals has signed a binding agreement to sell its gold assets to Metal Bank Limited in a share-and-cash deal, marking a strategic pivot towards rare earths and niobium development.

Island Pharmaceuticals has submitted a detailed briefing to the FDA aiming to accelerate approval of its antiviral Galidesivir for Marburg virus under the Animal Rule, with feedback expected by November.

Bravura Solutions has appointed Colin Greenhill as its new Group CEO, effective 1 January 2026, following a comprehensive global search. Greenhill brings over 15 years of leadership experience in financial services software, signaling a strategic step forward for the company.

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

Synlait Milk Limited reports a modest profit turnaround in FY25 and announces a major sale of its North Island assets to Abbott, aiming to reduce debt and sharpen its focus on core operations.